기본 정보
- 표준 SMILES
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl- InChIKey
BQKADKWNRWCIJL-UHFFFAOYSA-N- 분자식
- C18H24ClNO3
- 평균 분자량
- 337.8 g/mol
- 단동위원소 질량
- 337.14447131
개요
Dobutamine Hydrochloride is the hydrochloride salt form of dobutamine, a synthetic catecholamine with direct inotropic activity. Dobutamine hydrochloride, mimics the effects of dopamine and stimulates beta-1 adrenergic receptors located in the myocardium. This leads to an increase in heart rate and force and results in an increase in cardiac output.
이름 및 식별자
- 우선 이름
- Dobutamine Hydrochloride
- IUPAC
- 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
- 영어명
- dobutamine hydrochloride
- 분자식
- C18H24ClNO3
- 분자량
- 337.84106
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
49745-95-1、52663-81-7- PubChem CID
- 65324
- DTXSID
DTXSID30964383- ChEMBL
CHEMBL1200418- UNII
- 0WR771DJXV
- EC Number
- 256-464-1
물성
구조 계산 물성
- 극성 표면적
- 72.7 Ų
- 수소 결합 공여자 수
- 5
- 수소 결합 수용자 수
- 4
- 회전 가능 결합 수
- 7
- 무거운 원자 수
- 23
- 형식 전하
- 0
- 복잡도
- 305
실험 및 물리화학적 성질
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
안전 및 규제
GHS 분류
GHS Classification
Warning
H302 (95.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
유해성 정보
독성 정보
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Dobutamine hydrochloride
vNo-DILI-concern
0
No match
DOI:10.1016/j.drudis.2016.02.015
안전 데이터
- 위험 등급
- IRRITANT
화학 및 산업
약리 정보
FDA Pharmacological Classification
DOBUTAMINE HYDROCHLORIDE
beta-Adrenergic Agonist [EPC]; Adrenergic beta-Agonists [MoA]
DOBUTAMINE IN DEXTROSE
beta-Adrenergic Agonist [EPC]; Adrenergic beta-Agonists [MoA]
MeSH Pharmacological Classification
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.
공급사3 곳
관련 반응
연결된 노트
불러오는 중…